Oocyte and ovarian tissue cryopreservation in European countries: Statutory background, practice, storage and use

Human Reproduction Open

Volumn 2017, Issue 1, 2017, Pages

  Shenfield, F ^a   de Mouzon, J ^b   Scaravelli, G ^c   Kupka, M ^d   Ferraretti, A P ^e   Prados, F J ^f   Goossens, V ^g  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b Surveillance and Health Promotion Istituto Superiore di Sanità ^*  (France)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d Reproductive Medicine Center   (Germany)

^e SISMER   (Italy)

^f HM Fertility Center Montepríncipe Boadilla del Monte   (Spain)

^g Central Office   (Belgium)

Author keywords

Access; European data; Funding; Medical and non medical indications; Oocyte cryopreservation; Ovarian tissue cryopreservation

Indexed keywords

ADULT; AGE; ARTICLE; BIOLOGICAL MONITORING; CLINICAL PRACTICE; CONTROLLED STUDY; CRYOPRESERVATION; EUROPE; FEMALE; FINANCIAL MANAGEMENT; FOLLICULAR ASPIRATION; FREEZE THAWING; FREEZING; HEALTH CARE POLICY; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT NEOPLASM; OOCYTE; OOCYTE CRYOPRESERVATION; OVARIAN TISSUE CRYOPRESERVATION; OVARY TISSUE; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; TISSUE PRESERVATION;

EID: 85053575752     PISSN: None     EISSN: 23993529     Source Type: Journal    
DOI: 10.1093/hropen/hox003     Document Type: Article

References (47)

1. Argyle CE, Harper J, Davies MC. Oocyte cryopreservation: where are we now? Hum Reprod Update 2016;22:440-449
2. Arrêté du 24 décembre 2015 pris en application de l'article L. 2141-1 du code de la santé publique et modifiant l'arrêté du 3 août 2010 modifiant l'arrêté du 11 avril 2008 relatif aux règles de bonnes pratiques cliniques et biologiques d'assistance médicale à la procréation NOR: AFSP1532457A, JO
3. Avraham S, Machtinger R, Cahan T, Sokolov A, Racowsky C, Seidman DS. What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics? Fertil Steril 2014;101:222-226
4. Baldwin K, Culley L, Hudson N, Mitchell H, Lavery S. Oocyte cryopreservation for social reasons. Demographic profile and disposal intentions of UK users. Reprod Biomed Online 2015;31:239-245
5. Bastings L, Baysal O, Beerendonk CC, IntHout J, Traas MA, Verhaak CM, Braat DD, Nelen WL. Deciding about fertility preservation after specialist counselling. Hum Reprod 2014;29:1721-1729
6. Benagiano G, Gianaroli L. The new Italian IVF legislation. Reprod Biomed Online 2004;9:117-125
7. Cobo A, Meseguer M, Remohi J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum Reprod 2010;25:2239-2246
8. Cobo A, Garcia-Velasco JA, Coello A, Domingo J, Pellicer A, Remohi J. Oocytes vitrification as an efficient option for elective fertility preservation (EFP). Fertil Steril 2016;105:755-764
9. Décret no 2015-1281 du 13 octobre 2015 relatif au don de gamètes NOR: AFSP1513121D, Journal officiel
10. De Roo C, Tilleman K, T'Sjoen G, De Sutter P. Fertility options in transgender people. Int Rev Psychiatry 2016;28:112-119
11. Dondorp WJ, De Wert GMWR. Fertility preservation for healthy women: ethical aspects. Hum Reprod 2009;24:1779-1785
12. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410
13. ESHRE Task Force on Ethics and Law 1. The moral status of the preimplantation embryo. Hum Reprod 2001;16:1046-1048
14. ESHRE Task Force on Ethics and Law 2. The cryopreservation of human embryos. Hum Reprod 2001;16:1049-1050
15. ESHRE Taskforce on Ethics and Law 15. Cross border reproductive care. Hum Reprod 2008;23:2182-2184
16. ESHRE Task Force on Ethics and Law 18 including, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P, Diedrich K. Oocyte cryopreservation for age related fertility loss. Hum Reprod 2012; 27:1231-1237
17. Evans v. UK, 43 E.H.R.R. 21, 2007 http://hudoc.echr.coe.int/eng?i=001-80046 (25 March 2017, date last accessed)
18. FertiPROTEKT. Network for Fertility Preservation Before Chemo-and Radiotherapy. www.fertiprotekt.eu. Accessed January 2016
19. Freedom of Information Act 2000. www.legislation.gov.uk/ukpga/2000/36 (25 March 2017, date last accessed)
20. Homburg R, Van der Veen F, Silber SJ. Oocyte vitrification-womens' emancipation set in stone. Fertil Steril 2009;91:1319-1320
21. Kupka MS, D'Hooghe T, Ferraretti AP, de Mouzon J, Erb K, Castilla JA, Calhaz-Jorge C, De Geyter C, Goossens V, The European IVFMonitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE. Hum Reprod 2016;31:232-248
22. HFE Act 2008. www.dh.gov.uk/en/Legislation/Actsandbills/DH_080211 (25 March 2017, date last accessed)
23. HFEA Annual Results, www.hfea.gov.uk/9461.htm (25 March 2017, date last accessed)
24. Lockwood GM. Social egg freezing: the prospect of reproductive 'immortality' or a dangerous delusion? Reprod Biomed Online 2011;23:334-340
25. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, Partridge AH, Quinn G, Wallace WH, Oktay K. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500-2510
26. Lucas N, Rosario R, Shelling A. New Zealand University students' knowledge of fertility decline in women via natural pregnancy and assisted reproductive technologies. Hum Fertil 2015;18:208-214
27. Mc Donagh. Chemotherapy patient challenges NHS fertility preservation refusal. Bionews 2014;750. www.bionews.org.uk
28. Mertes H, Pennings G. Social egg freezing: for better, not for worse. Reprod Biomed Online 2011;23:824-829
29. Mertes H, Pennings G. Elective oocyte cryopreservation: who should pay? Hum Reprod 2012;27:9-13
30. Mills M, Rindfuss RR, McDonald P, Te Velde E. Why do people postpone parenthood?: reasons and social policy incentives. Hum Reprod Update 2011;17:848-860
31. NICE Guidelines [CG156] 2013, nice.org.uk/guidance/CG156 (25 March 2017, date last accessed)
32. Oktay K, Kan MT, Rosenwaks Z. Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol 2001;13:263-268
33. Oktay K, Bedoschi G, Berkowitz K, Bronson R, Kashani B, McGovern P, Pal L, Quinn G, Rubin K. Fertility preservation in women with turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol 2015;29:409-416
34. Practice Committee of American Society for Reproductive Medicine. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013;99:37-43
35. Rienzi L, Romano S, Albricci L, Maggiulli R, Capalbo A, Baroni E, Colamaria S, Sapienza F, Ubaldi F. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized siblingoocyte study. Hum Reprod 2010;25:66-73
36. Shenfield F, de Mouzon J, Pennings G, Ferraretti AP, Andersen AN, de Wert G, Goossens V; ESHRE Taskforce on Cross border Reproductive Care. Cross border reproductive care in six European countries Hum Reprod 2010;25:1361-1368
37. Somigliana E, Vigano P, Filippi F, Papaleo E, Benaglia L, Candiani M, Vercellini P. Fertility preservation in women with endometriosis: for all, for some, for none ? Hum Reprod 2015;30:1280-1286
38. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for nonmedical reasons among women of reproductive age. Hum Reprod 2011a;26:655-661
39. Stoop D, van der Veen F, Deneyer M, Nekkebroeck J, Tournaye H. Oocyte banking for anticipated gamete exhaustion (AGE) is a preventative intervention, neither social nor nonmedical. Reprod Biomed Online 2011b;28:548-551
40. Stoop D, Cobo A, Silber S. Fertility preservation for age-related fertility decline. The Lancet 2014;384:1311-1319
41. Stoop D, Maes E, Polyzos NP, Verheyen G, Tournaye H, Nekkebroeck J. Does oocyte banking for anticipated gamete exhaustion influence future relational and reproductive choices? A follow-up of bankers and nonbankers. Hum Reprod 2015;30:338-344
42. Stoop D. Oocyte vitrification for elective fertility preservation: lessons for patient counselling. Fertil Steril 2016;105:603-604
43. Van der Ven H, Liebenthron J, Beckmann M, Toth B, Korell M, Krüssel J, Frambach T, Kupka M, Hohl MK, Winkler-Crepaz K et al., FertiPROTEKT network. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates. Hum Reprod 2016;31:2031-2041
44. von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B. Fertility preservation in women-a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and border-line ovarian tumours by the fertility preservation network FertiPROTEKT. Arch Gynecol Obstet 2011;284:427-435
45. Wallace SA, Blough KL, Kondapalli LA. Fertility preservation in the transgender patient: expanding oncofertility care beyond cancer. Gynecol Endocrinol 2014;30:868-871
46. Wallace WH, Kelsey TW, Anderson RA. Fertility preservation in prepubertal girls with cancer: the role of ovarian tissue cryopreservation. Fertil Steril 2016;105:6-12
47. Yu L, Peterson B, Inhorn MC, Boehm JK, Patrizio P. Knowledge, attitudes, and intentions toward fertility awareness and oocyte cryopreservation among obstetrics and gynecology resident physicians. Hum Reprod 2016; 31:403-411